Cargando…
Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica
Background: Multiple sclerosis (MS) and neuromyelitis optica (NMO) are both demyelinating disorders and oxidative stress is suggested to have a role in their pathogenesis. Glucose-6-phosphate dehydrogenase (G6PD) produces nicotinamide adenine dinucleotide phosphate (NADPH) via the pentose phosphate...
Autores principales: | Chitsaz, Niloofar, Dehghani, Leila, Safi, Amir, Esmalian-Afyouni, Nazgol, Shaygannejad, Vahid, Rezvani, Majid, Sohrabi, Karim, Moridi, Kaykhosro, Moayednia, Milad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036045/ https://www.ncbi.nlm.nih.gov/pubmed/32117550 |
Ejemplares similares
-
The Serum Level of Midkine in Patients With Multiple Sclerosis and Neuromyelitis Optica
por: Moayednia, Milad, et al.
Publicado: (2021) -
Screening neuromyelitis optica patients for COVID-19 infection
por: Mirmosayyeb, Omid, et al.
Publicado: (2020) -
Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study
por: Ashtari, Fereshte, et al.
Publicado: (2017) -
Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
por: Motahharynia, Ali, et al.
Publicado: (2022) -
Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS)
por: Mirmosayyeb, Omid, et al.
Publicado: (2021)